User:NEXS BSG/sandbox

Shola Oyewole

Shola Oyewole is the Chief Information Officer at United Therapeutics Corporation, providing technology vision and leadership in the development and implementation of the global information technology program. He provides strategic and tactical planning, budget development, evaluation and coordination of the information and technology systems for the corporation. Additionally, he supports various business units, including Finance, HR, R&D, Manufacturing, Sales and Marketing, with planning and implementing enterprise information systems to support both distributed and centralized business operations and achieving more effective and cost beneficial enterprise-wide IT solutions. He also facilitates communication between staff, management, vendors, business partners and other technology resources within and outside the organization. Furthermore, Mr. Oyewole is responsible for the management of multiple information and communication solutions as well as the design, evaluation, and implementation of the systems that support end-users. He is a senior partner of the Risk Council and is responsible for the Information Security & Data Governance programs. Shola joined United Therapeutics in 2000 when it was still a start-up, and works with management to this day to maintain this entrepreneurial and nimble spirit.

Oyewole was formerly the Manager of Information Systems at Information Strategy in Washington, DC, a Microsoft Gold Certified Partner providing IT solutions to government and business customers, focusing on a line of business solutions, portals, customer relationship management, Microsoft Surface, and custom database applications and integration.

Prior to this, he was a Project Manager and Senior Systems Engineer at WANG Global (Advanced Paradigms, Inc.), leading and architecting several infrastructure projects for clients such as INTELSAT and the Center for Naval Analyses, both in the DC area.

Oyewole has provided consulting services in the information technology business, in various industries, for over 25 years, and holds an MBA from George Washington University, an MSc in the Management of Information Systems from the American University, and a BSc in Electronics Engineering from the University of Ife, Nigeria. He recently served on the Boards of Global Six Communications (a tele-health start-up); the American Lung Association; and The Loop, a social media start-up founded by his son.

United Therapeutics Corporation (NASDAQ: UTHR) is a biotechnology company, founded by Martine Rothblatt, focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Quality of life for their patients is their utmost therapeutic goal. Currently, their revenue-generating products are all in the field of cardiovascular medicine, but they are also laying important foundations for future franchises in the treatment of cancer and infectious diseases. UTC’s 2015 sales were $1.47 billion.